Targeting GM-CSF: A New Approach to COVID?

(MedPage Today) -- Treatment with the investigational monoclonal antibody mavrilimumab significantly improved outcomes among patients with severe COVID-19 also given standard of care treatment, an international phase II randomized trial found...